Description

1H-Indole,1-[(2-Ethyl-2,3-Dihydro-6-Methyl-3-Oxo-4H-1,4-Benzoxazin-4-Yl)Acetyl]-2,3-Dihydro-(9Ci) is a high-purity, complex heterocyclic compound designed for advanced research and development applications. This specialty chemical serves as a critical building block or intermediate in the synthesis of novel molecules, particularly in the pharmaceutical and agrochemical sectors. It is essential for scientists and process chemists working on the development of new active ingredients, where precise molecular structure and reliable quality are paramount.

Application

• Pharmaceutical Intermediate: Key starting material or advanced intermediate in the synthesis of novel drug candidates, particularly those targeting neurological or metabolic pathways.
• Agrochemical Research: Used in the development of new herbicides, fungicides, or insecticides, leveraging its unique indole-benzoxazine hybrid structure.
• Chemical Synthesis: Serves as a versatile scaffold for constructing complex heterocyclic libraries in medicinal chemistry and combinatorial chemistry.
• Biochemical Research: Potential use as a probe or inhibitor in enzymatic studies due to its specific molecular architecture.
• Material Science Precursor: May be utilized in the development of organic electronic materials or advanced polymers.

Basic Information

Product Name	1H-Indole,1-[(2-Ethyl-2,3-Dihydro-6-Methyl-3-Oxo-4H-1,4-Benzoxazin-4-Yl)Acetyl]-2,3-Dihydro-(9Ci)
CAS No.	606120-20-1
Molecular Formula	C21H20N2O3
Molecular Weight	348.40 g/mol
Synonyms	1-[(2-Ethyl-3-oxo-6-methyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl)acetyl]-2,3-dihydro-1H-indole; 1-[(2-Ethyl-2,3-dihydro-6-methyl-3-oxo-4H-1,4-benzoxazin-4-yl)acetyl]indoline; 4-[2-(2,3-Dihydro-1H-indol-1-yl)-2-oxoethyl]-2-ethyl-6-methyl-2H-1,4-benzoxazin-3(4H)-one; Indoline-1-carboxylic acid, (2-ethyl-6-methyl-3-oxo-4H-1,4-benzoxazin-4-yl)-, (9CI); 606120-20-1; Contact for additional trade names.
EINECS	Contact for details

Quality Control

Our 1H-Indole,1-[(2-Ethyl-2,3-Dihydro-6-Methyl-3-Oxo-4H-1,4-Benzoxazin-4-Yl)Acetyl]-2,3-Dihydro-(9Ci) is manufactured under a strict quality management system. Every batch undergoes comprehensive analytical testing to ensure identity, purity, and consistency. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting key parameters such as assay, related substances, and residual solvents. We support compliance with cGMP and ISO standards for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed to exclude moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Loss on Drying	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.